130 related articles for article (PubMed ID: 30397360)
1. Genetic variation determines VEGF-A plasma levels in cancer patients.
Innocenti F; Jiang C; Sibley AB; Etheridge AS; Hatch AJ; Denning S; Niedzwiecki D; Shterev ID; Lin J; Furukawa Y; Kubo M; Kindler HL; Auman JT; Venook AP; Hurwitz HI; McLeod HL; Ratain MJ; Gordan R; Nixon AB; Owzar K
Sci Rep; 2018 Nov; 8(1):16332. PubMed ID: 30397360
[TBL] [Abstract][Full Text] [Related]
2. Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis.
Paradowska-Gorycka A; Pawlik A; Romanowska-Prochnicka K; Haladyj E; Malinowski D; Stypinska B; Manczak M; Olesinska M
PLoS One; 2016; 11(8):e0160769. PubMed ID: 27513931
[TBL] [Abstract][Full Text] [Related]
3. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
4. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
Hofmann G; Langsenlehner U; Renner W; Langsenlehner T; Yazdani-Biuki B; Clar H; Gerger A; Wehrschuetz M; Samonigg H; Krippl P
J Cancer Res Clin Oncol; 2008 May; 134(5):591-5. PubMed ID: 17938959
[TBL] [Abstract][Full Text] [Related]
5. Comparison of angiogenic factor levels in tumor drainage and peripheral venous blood from colorectal cancer patients.
Tien YW; Chang KJ; Chiu YF; Huang KW; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1357-63. PubMed ID: 17001510
[TBL] [Abstract][Full Text] [Related]
6. Correlation of plasma level and immunohistochemical expression of vascular endothelial growth factor in patients with advanced colorectal cancer.
Minagawa N; Nakayama Y; Hirata K; Onitsuka K; Inoue Y; Nagata N; Itoh H
Anticancer Res; 2002; 22(5):2957-63. PubMed ID: 12530025
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor pathway in endometriosis: genetic variants and plasma biomarkers.
Vodolazkaia A; Yesilyurt BT; Kyama CM; Bokor A; Schols D; Huskens D; Meuleman C; Peeraer K; Tomassetti C; Bossuyt X; Lambrechts D; D'Hooghe T; Fassbender A
Fertil Steril; 2016 Apr; 105(4):988-96. PubMed ID: 26773192
[TBL] [Abstract][Full Text] [Related]
8. Association of vascular endothelial growth factor single nucleotide polymorphisms on the prognosis of breast cancer patients.
Rani J; Rahul B; Ramesh G; Krishnamoorthy L; Shilpa C; Ramaswamy G; Deshmane V
Indian J Cancer; 2014; 51(4):512-7. PubMed ID: 26842181
[TBL] [Abstract][Full Text] [Related]
9. Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis.
Garcia V; Garcia JM; Silva J; Peña C; Dominguez G; Lorenzo Y; Diaz R; Alonso I; Colas A; Hurtado A; Sanchez A; Bonilla F
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1165-71. PubMed ID: 18461364
[TBL] [Abstract][Full Text] [Related]
10. The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer.
Hansen TF; Spindler KL; Lorentzen KA; Olsen DA; Andersen RF; Lindebjerg J; Brandslund I; Jakobsen A
J Cancer Res Clin Oncol; 2010 May; 136(5):751-8. PubMed ID: 19904558
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.
Bocci G; Man S; Green SK; Francia G; Ebos JM; du Manoir JM; Weinerman A; Emmenegger U; Ma L; Thorpe P; Davidoff A; Huber J; Hicklin DJ; Kerbel RS
Cancer Res; 2004 Sep; 64(18):6616-25. PubMed ID: 15374976
[TBL] [Abstract][Full Text] [Related]
12. Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance).
Quintanilha JCF; Sibley AB; Liu Y; Niedzwiecki D; Halabi S; Rogers L; O'Neil B; Kindler H; Kelly W; Venook A; McLeod HL; Ratain MJ; Nixon AB; Innocenti F; Owzar K
BMC Genomics; 2024 May; 25(1):473. PubMed ID: 38745123
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab.
Koutras AK; Antonacopoulou AG; Eleftheraki AG; Dimitrakopoulos FI; Koumarianou A; Varthalitis I; Fostira F; Sgouros J; Briasoulis E; Bournakis E; Bafaloukos D; Bompolaki I; Galani E; Kalogeras KT; Pectasides D; Fountzilas G; Kalofonos HP
Pharmacogenomics J; 2012 Dec; 12(6):468-75. PubMed ID: 21844885
[TBL] [Abstract][Full Text] [Related]
14. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of nuclear factor-kappaB/RelA is correlated with tumor angiogenesis in human colorectal cancer.
Yu HG; Zhong X; Yang YN; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
Int J Colorectal Dis; 2004 Jan; 19(1):18-22. PubMed ID: 12827408
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer.
Duff SE; Saunders M; McCredie V; Kumar S; O'Dwyer ST; Jayson GC
Clin Oncol (R Coll Radiol); 2005 Aug; 17(5):367-71. PubMed ID: 16097569
[TBL] [Abstract][Full Text] [Related]
17. Plasma VEGF-A and its soluble receptor R1 correlate with the clinical stage of colorectal cancer.
Myśliwiec P; Piotrowski Z; Zalewski B; Kukliński A; Pawlak K
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():85-7. PubMed ID: 15638384
[TBL] [Abstract][Full Text] [Related]
18. VEGF gene polymorphisms and susceptibility to colorectal cancer.
Jannuzzi AT; Özhan G; Yanar HT; Alpertunga B
Genet Test Mol Biomarkers; 2015 Mar; 19(3):133-7. PubMed ID: 25635747
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum angiogenic activity in colorectal cancer patients.
Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
[TBL] [Abstract][Full Text] [Related]
20. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]